AzTrials
AzTrials

Dental CariesPhase 2NCT01604109

Effect of CPP-ACP Paste on Dental Caries in Primary Teeth

A Phase 2 study testing 10 % w/v CPP-ACP paste and the paste without CPP-ACP in people with Dental Caries, run by Thammasat University at 1 site in Thailand.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The purpose of this study is to determine if adding daily application of CPP-ACP containing paste for one year is superior to regular fluoride tooth brushing in preventing dental caries in high caries risk Thai preschool children. Read more about this study

Who is it for?
Ages 30 to 42 monthsHealthy volunteers can take part
Conditions the study is for
Dental Caries
What is being tested?
10 % w/v CPP-ACP paste and the paste without CPP-ACP
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
296 participants
Where
1 siteThailand
Study dates
Jul 2010to Sep 2011
Phase
Phase 2
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 to 42 months
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • Healthy Thai boys and girl aged between 2 1/2 - 3 1/2
  • Normal development of dentition
  • Diagnosed as high caries risk by using the Caries-risk Assessment Tool(CAT)

Who cannot join

  • Chronic use of medications or antibiotics.
  • Lack of cooperation in oral examination
  • Milk protein allergy and/or benzoate preservatives
  • Presence at baseline oral soft tissue lesion and enamel hypoplasia.
  • Receive fluoride supplement and professional topical fluoride application at least three months before the beginning of study or during study period

Trial locations and contacts

1 site in 1 country.

Thailand1 site
  • Faculty of Dentistry, Thammasat University

    Klongluang, Patumthani, 12121

Other trials in Thailand

About this study

Official title: Effect of CPP-ACP Paste on Dental Caries in Primary Teeth: A Randomized Trial

The purpose of this study is to determine if adding daily application of CPP-ACP containing paste for one year is superior to regular fluoride tooth brushing in preventing dental caries in high caries risk Thai preschool children.

Read the detailed description

The 6th National Oral Health Survey in Thailand 2006-2007 reported that 3-year-old children who resided in central part have the highest dental caries prevalence of 69.8 percent with dmft affecting 3.63 teeth on average. Fluoride is widely accepted as the most effective tool to caries prevention for initial caries lesions. Current best practice recommends twice-daily tooth brushing with fluoride toothpaste for dentate children.

CPP-ACP can bolster the effects of fluoridated toothpaste alone to prevent caries.Currently, almost all clinical trials have investigated the effectiveness of CPP-ACP containing products in dental caries prevention and enhancing remineralization of initial carious lesion in the permanent dentition of young adolescents. There are no clinical studies of the effect of a CPP-ACP containing product to prevent dental caries in the primary dentition of young children.

Conditions
Dental Caries
Being tested
10 % w/v CPP-ACP paste, the paste without CPP-ACP
Keywords
Caries detection/diagnosis/prevention, Preventive Dentistry, Casien Phosphopeptide, Remineralization, Clinical trial
Medical subject headings
Dental Caries

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 10 % w/v CPP-ACP pasteDrug

    Also called Tooth Mousse

    Apply once a day at school by school teacher, following fluoride toothbrushing after lunch

  • the paste without CPP-ACPDrug

    Apply once a day at school by school teacher, following fluoride toothbrushing after lunch.

Study groups in NCT01604109
Study groupRoleWhat they receive
Tooth MousseActive comparator10% w/v Calcium Phosphopeptide Amorphous Calcium Phosphate paste
Receives: Drug: 10 % w/v CPP-ACP paste
placebo control pastePlacebo comparatorthe paste without Calcium phosphopeptide - Amorphous Calcium Phosphate
Receives: Drug: the paste without CPP-ACP

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. the Mean Number of Enamel Carious Lesion

    tooth surface that was classified as ICDAS code 1-3

    Measured: one calender year

Secondary outcomes (1)
  1. Quantitative Light-induced Fluorescence (QLF) Parameters

    percent fluorescence loss, lesion area, lesion volume

    Measured: one calender year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted23 May 2012 (estimated)
  2. Study startJul 2010
  3. Primary completionSep 2011
  4. Study completionSep 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 2
Primary purpose
Prevention
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
296 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01604109
Sponsor's protocol ID
TU-Dent-01
Other IDs
D43TW007768
Status last verified
Jun 2013
First submitted
19 May 2012
Last updated
15 Aug 2013
Data monitoring committee
No

Publications

  • Sitthisettapong T, Phantumvanit P, Huebner C, Derouen T. Effect of CPP-ACP paste on dental caries in primary teeth: a randomized trial. J Dent Res. 2012 Sep;91(9):847-52. doi: 10.1177/0022034512454296. Epub 2012 Jul 17.

    PubMed 22805294

Questions about this trial

What is this clinical trial studying?

A Phase 2 study testing 10 % w/v CPP-ACP paste and the paste without CPP-ACP in people with Dental Caries, run by Thammasat University at 1 site in Thailand.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Aug 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Thailand. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 2 studies give the treatment to a larger group to see whether it has the intended effect and to keep checking safety.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

Yes. Results are posted in the registry (first posted 15 Aug 2013). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

the Mean Number of Enamel Carious Lesion (time frame: one calender year). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01604109, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Aug 2013.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in